84 related articles for article (PubMed ID: 23224486)
1. Aripiprazole for the treatment of involuntary movement symptoms in patients with major depressive disorder.
Kang WS; Park JK; Cho AR
J Neuropsychiatry Clin Neurosci; 2012; 24(4):E5-6. PubMed ID: 23224486
[No Abstract] [Full Text] [Related]
2. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole-related subcortical growth in a patient with major depressive disorder and panic disorder.
Lai CH
J Clin Psychopharmacol; 2010 Aug; 30(4):474-6. PubMed ID: 20631573
[No Abstract] [Full Text] [Related]
4. Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.
Grant MJ; Baldessarini RJ
Ann Pharmacother; 2005 Nov; 39(11):1953. PubMed ID: 16219895
[No Abstract] [Full Text] [Related]
5. Aripiprazole monotherapy in a patient with major depressive disorder.
Yokoyama Y; Kitamura H; Someya T
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1124-5. PubMed ID: 20398715
[No Abstract] [Full Text] [Related]
6. Aripiprazole monotherapy-related gray-matter growth in a patient with first-episode drug-naïve non-psychotic major depressive disorder.
Lai CH
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E49-50. PubMed ID: 23037685
[No Abstract] [Full Text] [Related]
7. Potential utility of aripiprazole monotherapy for the treatment of major depressive disorder comorbid with obsessive-compulsive disorder.
Pae CU
Psychiatry Clin Neurosci; 2009 Aug; 63(4):593. PubMed ID: 19659566
[No Abstract] [Full Text] [Related]
8. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.
Goforth HW; Carroll BT
J Clin Psychopharmacol; 2007 Apr; 27(2):216-7. PubMed ID: 17414252
[No Abstract] [Full Text] [Related]
11. Aripiprazole as an adjunctive treatment for refractory major depression.
Hellerstein DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1347-8. PubMed ID: 15588762
[No Abstract] [Full Text] [Related]
12. Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.
Wisniewski SR; Chen CC; Kim E; Kan HJ; Guo Z; Carlson BX; Tran QV; Pikalov A
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):965-72. PubMed ID: 19662630
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole in depersonalization disorder comorbid with major depression and obsessive-compulsive disorder: 3 cases.
Uguz F; Sahingoz M
Clin Neuropharmacol; 2014; 37(4):125-7. PubMed ID: 24992087
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.
Arbaizar B; Dierssen-Sotos T; Gómez-Acebo I; Llorca J
Gen Hosp Psychiatry; 2009; 31(5):478-83. PubMed ID: 19703642
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy.
Nelson JC; Thase ME; Bellocchio EE; Rollin LM; Eudicone JM; McQuade RD; Marcus RN; Berman RM; Baker RA
Int Clin Psychopharmacol; 2012 May; 27(3):125-33. PubMed ID: 22466058
[TBL] [Abstract][Full Text] [Related]
16. Normalization of prolactin with aripiprazole in a patient with psychotic depression and a comorbid pituitary microadenoma.
Steinhagen CK
Psychosomatics; 2007; 48(4):350-1. PubMed ID: 17600173
[No Abstract] [Full Text] [Related]
17. Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.
Tsai AC
J Clin Psychopharmacol; 2009 Feb; 29(1):91-2; author reply 92-3. PubMed ID: 19142118
[No Abstract] [Full Text] [Related]
18. Effectiveness of aripiprazole in treating obsessive compulsive symptoms.
Yang KC; Su TP; Chou YH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):585-6. PubMed ID: 18037548
[No Abstract] [Full Text] [Related]
19. Aripiprazole in refractory depression?
Carroll BJ
J Clin Psychopharmacol; 2009 Feb; 29(1):90-1; author reply 92-3. PubMed ID: 19142117
[No Abstract] [Full Text] [Related]
20. The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Boulton DW; Balch AH; Royzman K; Patel CG; Berman RM; Mallikaarjun S; Reeves RA
J Psychopharmacol; 2010 Apr; 24(4):537-46. PubMed ID: 18832427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
